Tag Archives: U.S.

Humira, Rituxan top list of U.S. drugs with biggest price increases: report

NEW YORK (Reuters) – AbbVie Inc’s arthritis drug Humira and Roche Holding AG’s cancer drug Rituxan topped a list of seven treatments whose combined 2017 and 2018 price hikes accounted for a $ 5.1 billion increase in U.S. spending, a report released on Tuesday showed. FILE PHOTO: A screen displays the share price for drugmaker… Read More »

GSK poaches Merck KGaA exec to replace departing U.S. pharma president Bailey

GlaxoSmithKline has seen plenty of changes across its executive ranks over the last couple of years as CEO Emma Walmsley took the helm, but they’re still coming. Monday, the company said Jack Bailey, its U.S. pharma president and a veteran at the drugmaker, would step down at the end of the year. He’ll be succeeded… Read More »